![](/img/cover-not-exists.png)
A Phase II Trial of Inotuzumab Ozogamicin Combined with Mini-HyperCVD as Salvage Therapy for Relapsed/Refractory ALL
Assi, Rita, Kantarjian, Hagop, Ravandi, Farhad, O'Brien, Susan Mary, Kebriaei, Partow, Short, Nicholas J., Thomas, Deborah A., Garcia-Manero, Guillermo, Champlin, Richard E., Kadia, Tapan M., Cortes,Volume:
17
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2017.07.032
Date:
September, 2017
File:
PDF, 88 KB
english, 2017